Market revenue in 2024 | USD 329.2 million |
Market revenue in 2030 | USD 384.2 million |
Growth rate | 2.6% (CAGR from 2025 to 2030) |
Largest segment | Reagents product |
Fastest growing segment | Others Product |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments Product, Reagents Product, Others Product |
Key market players worldwide | Abbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease molecular diagnostics market will help companies and investors design strategic landscapes.
Reagents product was the largest segment with a revenue share of 67.65% in 2024. Horizon Databook has segmented the Spain infectious disease molecular diagnostics market based on instruments product, reagents product, others product covering the revenue growth of each sub-segment from 2018 to 2030.
The infectious diseases molecular diagnostics market in Spain is likely to exhibit a CAGR of xx% during the forecast period. This growth is driven by increasing incidence of infectious diseases, technological advancements, and rising consumer awareness.
Consolidating laboratories is a growing trend in this market. This strategic move will not only enable scaling up of businesses, but also help companies expand their market presence. In addition, economic development is likely to have a positive impact on affordability and consequent market penetration of infectious diseases molecular diagnostics.
Early & accurate diagnosis and timely treatment would aid in reducing disease burden as well as mortality rate. Rising number of COVID-19 cases and poor accuracy rate of tests are expected to result in delay in testing & treatment, leading to low recovery rate in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain infectious disease molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Spain infectious disease molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account